DBVT
Price:
$17.415
Market Cap:
$589.78M
DBV Technologies S.A., a biopharmaceutical firm based in Montrouge, France, operates at the clinical stage, focusing on the research and development of epicutaneous immunotherapy solutions. Its flagship product, Viaskin Peanut, has completed Phase III clinical trials as an immunotherapy for peanut allergies in children aged 4 to 11, adolescents, and adults. The company's pipeline also includes Viaskin Milk, currently undergoing Phase I/II clinical trials for the treatment of Immunoglobulin E (IgE)-mediated cow's milk protein allergy, and Viaskin Egg, which is in pre-clinical development for hen's egg allergy. Additionally, DBV Technologies is developing a booster vaccine targeting Bordetella...[Read more]
Industry
Biotechnology
IPO Date
2014-10-22
Stock Exchange
NASDAQ
Ticker
DBVT
According to DBV Technologies S.A.’s latest financial reports and current stock price. The company's current ROE is -130.06%. This represents a change of 223.69% compared to the average of -40.18% of the last 4 quarters.
The mean historical ROE of DBV Technologies S.A. over the last ten years is -117.14%. The current -130.06% ROE has changed 11.03% with respect to the historical average. Over the past ten years (40 quarters), DBVT's ROE was at its highest in in the September 2023 quarter at 27.15%. The ROE was at its lowest in in the March 2025 quarter at -942.53%.
Average
-117.14%
Median
-90.07%
Minimum
-415.94%
Maximum
-47.16%
Discovering the peaks and valleys of DBV Technologies S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 701.76%
Maximum Annual ROE = -47.16%
Minimum Annual Increase = -78.22%
Minimum Annual ROE = -415.94%
| Year | ROE | Change |
|---|---|---|
| 2025 | -90.61% | -78.22% |
| 2024 | -415.94% | 701.76% |
| 2023 | -51.88% | 4.78% |
| 2022 | -49.51% | -49.75% |
| 2021 | -98.52% | 26.89% |
| 2020 | -77.65% | -13.26% |
| 2019 | -89.52% | -34.62% |
| 2018 | -136.93% | 20.45% |
| 2017 | -113.68% | 141.04% |
| 2016 | -47.16% | 240.01% |
The current ROE of DBV Technologies S.A. (DBVT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-186.14%
5-year avg
-141.29%
10-year avg
-117.14%
DBV Technologies S.A.’s ROE is greater than Larimar Therapeutics, Inc. (-134.14%), greater than Annexon, Inc. (-101.19%), greater than Altimmune, Inc. (-42.57%), greater than Korro Bio, Inc. (-117.86%), greater than enGene Holdings Inc. (-55.83%), greater than Amarin Corporation plc (-7.34%), greater than Alto Neuroscience, Inc. (-47.22%), greater than Lexeo Therapeutics, Inc. Common Stock (-47.48%), greater than Cellectis S.A. (-80.61%), greater than LB Pharmaceuticals Inc Common Stock (-17.68%),
| Company | ROE | Market cap |
|---|---|---|
| -134.14% | $296.96M | |
| -101.19% | $563.29M | |
| -42.57% | $230.35M | |
| -117.86% | $115.56M | |
| -55.83% | $82.94M | |
| -7.34% | $315.21M | |
| -47.22% | $753.47M | |
| -47.48% | $343.14M | |
| -80.61% | $310.29M | |
| -17.68% | $814.99M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like DBV Technologies S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like DBV Technologies S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is DBV Technologies S.A.'s ROE?
How is the ROE calculated for DBV Technologies S.A. (DBVT)?
What is the highest ROE for DBV Technologies S.A. (DBVT)?
What is the 3-year average ROE for DBV Technologies S.A. (DBVT)?
What is the 5-year average ROE for DBV Technologies S.A. (DBVT)?
How does the current ROE for DBV Technologies S.A. (DBVT) compare to its historical average?